AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates

AnaptysBio, Inc. (ANAB) came out with a quarterly loss of $1.59 per share versus the Zacks Consensus Estimate of a loss of$ 1.74. This compares to loss of $0.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.62%. A quarter ago, it was expected that this company would post a loss of$ 1.72 per share when it actually produced a loss of $1.41, delivering a surprise of 18.02%.Over the last four quarters, the company has surpasse ...